Use of solid phase automated sequencing to define HLA disparity between bone marrow donors and recipients.
Baxter-Lowe
L A
LA
Center for Cancer Treatment and Research, University of South Carolina, Columbia 29203.
Keever
C
C
Dinauer
D
D
Daniels
T
T
Johnson
K
K
Camitta
B
B
Drobyski
W
W
Garbrecht
F
F
Horowitz
M
M
Pietryga
D
D
D000483:Alleles; D001331:Automation; D001483:Base Sequence; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002460:Cell Line; D015235:HLA-B Antigens / Q000235:genetics* / Q000276:immunology; D006683:HLA-DQ Antigens / Q000235:genetics* / Q000276:immunology; D006684:HLA-DR Antigens / Q000235:genetics* / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D016133:Polymerase Chain Reaction / Q000379:methods; D014019:Tissue Donors
D015235:HLA-B Antigens; D006683:HLA-DQ Antigens; D006684:HLA-DR Antigens